Iovance Biotherapeutics (IOVA) Reports In-Line Q4 EPS

Iovance Biotherapeutics (NASDAQ: IOVA) reported Q4 EPS of ($0.64), in-line with the analyst estimate of ($0.64).

For earnings history and earnings-related data on Iovance Biotherapeutics (IOVA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Hermès can regain momentum despite China weakness, Jefferies says
• Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating